Skip to content
Tenfell
Awarded contract
Published 16 Jul 2018

NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

NHS England · London

Key facts

Awarded
19 Jun 2018
Contract starts
30 Jun 2018
Contract ends
30 Jun 2019
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 3 suppliers

SupplierValue
CSL Behring UK Ltd—
Shire Pharmaceuticals Limited—
Pharming Technologies NV—

Description

NHS Framework Agreement for the supply of Icatibant and C1-Esterase products for the treatment of Hereditary Angioedema. The framework will commence on 1st July 2018 for a period of 12 months until 30th June 2019, with options to extend up to a further 36 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.